Bayer

Chemist Lutz Ackermann Receives Bayer Foundation’s Hansen Family Award

16 Oct 2025

Articles tagged with 'export-stiftungen' | Bayer

16 Oct 2025

AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in Participants with Limb-Girdle Muscular Dystrophy 2I/R9

10 Oct 2025

Bayer and Kumquat Biosciences initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors

09 Oct 2025

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease

07 Oct 2025

AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting

03 Oct 2025

Bayer selects Interpublic as global media, production and creative agency partner for Consumer Health Division

03 Oct 2025

Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease

22 Sep 2025

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

22 Sep 2025

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

22 Sep 2025

View details about the software product Informachine News Trackers